Growth during the First Two Years of Life in Preterm Infants Who Developed Bronchopulmonary Dysplasia (BPD) and Received Initial Dexamethason (DXM) Therapy. † 1169 | Zendy

AI Assistant Blog Pricing

Growth during the First Two Years of Life in Preterm Infants Who Developed Bronchopulmonary Dysplasia (BPD) and Received Initial Dexamethason (DXM) Therapy. † 1169

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.